GFS
GILD icon

GYL Financial Synergies’s Gilead Sciences GILD Stock Holding History

GYL Financial Synergies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,234
Closed -$676K – 373
2024
Q1 		$676K Buy
9,234
+75
+0.8% +$5.77K 0.05% 211
2023
Q4 		$742K Sell
9,159
-844
-8% -$65.7K 0.06% 205
2023
Q3 		$750K Sell
10,003
-276
-3% -$21.2K 0.07% 203
2023
Q2 		$792K Buy
10,279
+63
+0.6% +$5.03K 0.07% 197
2023
Q1 		$848K Sell
10,216
-1,992
-16% -$165K 0.1% 136
2022
Q4 		$1.05M Buy
12,208
+1,597
+15% +$126K 0.23% 68
2022
Q3 		$655K Sell
10,611
-35
-0.3% -$2.21K 0.18% 77
2022
Q2 		$658K Buy
10,646
+1,793
+20% +$111K 0.18% 80
2022
Q1 		$526K Buy
+8,853
New +$566K 0.13% 102

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GYL Financial Synergies's GILD Position: Q2 2024 in Review

GYL Financial Synergies sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 9,234 shares — an estimated $676K sold.

GYL Financial Synergies first reported a position in GILD in Q1 2022 and held it in 9 quarters. The position peaked at $1.05M in Q4 2022. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • GYL Financial Synergies reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • GYL Financial Synergies sold 9,234 Gilead Sciences shares in Q2 2024, an estimated $676K.
  • GYL Financial Synergies first reported a position in Gilead Sciences in Q1 2022 and held it in 9 quarters.
  • GYL Financial Synergies's Gilead Sciences position peaked at $1.05M in Q4 2022.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on GYL Financial Synergies's 13F filing for Q2 2024, filed 23 Jul 2024.